236 related articles for article (PubMed ID: 8952659)
1. [Angiotensin II antagonists: a distinct therapeutic class].
Waeber B; Brunner HR
Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
[TBL] [Abstract][Full Text] [Related]
2. Losartan: the first angiotensin receptor antagonist in clinical use.
Beevers DG
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
[No Abstract] [Full Text] [Related]
3. Angiotensin II receptor inhibition. A new therapeutic principle.
Messerli FH; Weber MA; Brunner HR
Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
[TBL] [Abstract][Full Text] [Related]
4. [The medicine of the month. Losartan (Cozaar)].
Scheen AJ
Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
[No Abstract] [Full Text] [Related]
5. [Angiotensin-II receptor blockers].
Metelitsa VI
Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
[No Abstract] [Full Text] [Related]
6. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
Triggle DJ
Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
[No Abstract] [Full Text] [Related]
8. The future role of losartan.
Hansson L
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
[TBL] [Abstract][Full Text] [Related]
9. New angiotensin-II blocker.
Lilley LL; Guanci R
Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
[No Abstract] [Full Text] [Related]
10. Angiotensin receptor antagonists.
Goldsmith DJ
Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
[No Abstract] [Full Text] [Related]
11. [Angiotensin receptor antagonists. A new class of antihypertensive agents].
Mann J
Dtsch Med Wochenschr; 1996 Apr; 121(17):568-71. PubMed ID: 8620827
[No Abstract] [Full Text] [Related]
12. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
Velasquez MT
Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326
[TBL] [Abstract][Full Text] [Related]
13. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
Waeber B; Nussberger J; Brunner H
Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114
[No Abstract] [Full Text] [Related]
14. Losartan (Cozaar).
Baldinger S
Conn Med; 1996 May; 60(5):281-4. PubMed ID: 8998906
[No Abstract] [Full Text] [Related]
15. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Coca A; Giner V
Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists: the prototype losartan.
Schaefer KL; Porter JA
Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
[TBL] [Abstract][Full Text] [Related]
18. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
Brunner HR
J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
[No Abstract] [Full Text] [Related]
19. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
Lacourcière Y
Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
[TBL] [Abstract][Full Text] [Related]
20. The diversified pharmacology of angiotensin II-receptor blockade.
Timmermans PB; Smith RD
Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
